BON — Bon Natural Life Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual income statement for Bon Natural Life, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	R2022 September 30th	R2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	20-F	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	18.2	25.5	29.9	29.5	23.8
Cost of Revenue
Gross Profit	5.2	7.11	9.42	8.84	7.11
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	14.8	20.1	23.3	23.6	22
Operating Profit	3.47	5.4	6.6	5.94	1.87
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3.65	5.43	7.57	5.57	0.716
Provision for Income Taxes
Net Income After Taxes	3.1	4.61	6.3	4.57	0.365
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	3.03	4.59	6.24	4.6	0.398
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3.03	4.59	6.24	4.6	0.398
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.76	6.85	7.5	5.02	0.174
Special Dividends per Share